GB2104382B - Pharmaceutical formulations comprising human insulin and human c-peptide - Google Patents

Pharmaceutical formulations comprising human insulin and human c-peptide

Info

Publication number
GB2104382B
GB2104382B GB08224484A GB8224484A GB2104382B GB 2104382 B GB2104382 B GB 2104382B GB 08224484 A GB08224484 A GB 08224484A GB 8224484 A GB8224484 A GB 8224484A GB 2104382 B GB2104382 B GB 2104382B
Authority
GB
United Kingdom
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08224484A
Other languages
English (en)
Other versions
GB2104382A (en
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB2104382A publication Critical patent/GB2104382A/en
Application granted granted Critical
Publication of GB2104382B publication Critical patent/GB2104382B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB08224484A 1981-08-27 1982-08-26 Pharmaceutical formulations comprising human insulin and human c-peptide Expired GB2104382B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
GB2104382A GB2104382A (en) 1983-03-09
GB2104382B true GB2104382B (en) 1984-12-19

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08224484A Expired GB2104382B (en) 1981-08-27 1982-08-26 Pharmaceutical formulations comprising human insulin and human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A ( )
AU (1) AU551879B2 ( )
BE (1) BE894185A ( )
CA (1) CA1176158A ( )
CH (1) CH650679A5 ( )
DE (1) DE3232034A1 ( )
DZ (1) DZ452A1 ( )
FR (1) FR2513126B1 ( )
GB (1) GB2104382B ( )
IE (1) IE54119B1 ( )
IL (1) IL66611A0 ( )
IT (1) IT1153182B ( )
LU (1) LU84359A1 ( )
MW (1) MW3882A1 ( )
NL (1) NL192192C ( )
NZ (1) NZ201682A ( )
PH (1) PH19361A ( )
SE (1) SE460334B ( )
ZA (1) ZA826159B ( )
ZW (1) ZW17482A1 ( )

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
EP0280534B1 (en) * 1987-02-25 1993-04-21 Novo Nordisk A/S Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
US8263551B2 (en) 2004-11-22 2012-09-11 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
JP5765813B2 (ja) 2008-09-19 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション 治療用ペプチドのポリマーコンジュゲート
WO2011146518A2 (en) 2010-05-17 2011-11-24 Cebix Inc. Pegylated c-peptide
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
CH650679A5 (de) 1985-08-15
SE460334B (sv) 1989-10-02
FR2513126A1 (fr) 1983-03-25
NZ201682A (en) 1985-08-16
NL192192C (nl) 1997-03-04
JPS5846024A (ja) 1983-03-17
MW3882A1 (en) 1984-07-11
IT8223017A0 (it) 1982-08-27
DE3232034C2 ( ) 1991-04-11
SE8204873L (sv) 1983-02-28
NL192192B (nl) 1996-11-01
AU8759482A (en) 1983-03-03
CA1176158A (en) 1984-10-16
IE822064L (en) 1983-02-27
DZ452A1 (fr) 2004-09-13
AU551879B2 (en) 1986-05-15
IT1153182B (it) 1987-01-14
DE3232034A1 (de) 1983-03-10
ZW17482A1 (en) 1982-11-17
IE54119B1 (en) 1989-06-21
LU84359A1 (fr) 1983-02-28
ZA826159B (en) 1984-04-25
GB2104382A (en) 1983-03-09
SE8204873D0 (sv) 1982-08-25
FR2513126B1 (fr) 1986-04-18
PH19361A (en) 1986-04-02
BE894185A (fr) 1983-02-24
NL8203315A (nl) 1983-03-16
IL66611A0 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
GB2104382B (en) Pharmaceutical formulations comprising human insulin and human c-peptide
AU549066B2 (en) Preparation of human insulin
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
GB2104380B (en) Human proinsulin pharmaceutical formulations
ZW17682A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
JPS57209227A (en) Insulin medicine and manufacture
IE812104L (en) Novel insulin formulations based on human insulin
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide
IE822065L (en) Insulin and proinsulin formulations
JO1209B1 (en) Pharmacy formulations that include human insulin and the human insulin component.

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20020825